InvestorsHub Logo
Followers 27
Posts 784
Boards Moderated 0
Alias Born 08/01/2019

Re: None

Saturday, 04/18/2020 10:53:39 AM

Saturday, April 18, 2020 10:53:39 AM

Post# of 20440
$TOMDF Currently in a pre-commercial study with its distribution partner Orot+ (a division of Luces-Orot). Orot has a proven track record of over 3 decades developing breakthrough technologies which will significantly impact cancer care.